Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Clinical Chemistry and Laboratory Medicine|October 4, 2005
Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration projectAnne L Morkbak, Randi M Heimdal, Kathleen Emmens, et al.
Clinical Chemistry|January 8, 2004
Facts and recommendations about total homocysteine determinations: an expert opinionHelga Refsum, A David Smith, Per M Ueland, et al.
The American Journal of Clinical Nutrition|January 15, 2010
Daily intake of 4 to 7 microg dietary vitamin B-12 is associated with steady concentrations of vitamin B-12-related biomarkers in a healthy young populationMustafa Vakur Bor, Kristina M von Castel-Roberts, Gail Pa Kauwell, et al.
Clinical Chemistry|September 27, 2002
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled studyEbba Nexo, Anne-Mette Hvas, Øyvind Bleie, et al.
Clinical Biochemistry|February 7, 2012
Elevated vitamin B₁₂ levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytesRaffick A R Bowen, Kennichi C Dowdell, Janet K Dale, et al.
BMC Primary Care|November 7, 2025
Patient-reported characteristics of pernicious anaemia: a first step to initiate James Lind Alliance Priority Setting Partnership driven researchAlfie Thain, Petra Visser, Kathryn Hart, et al.
Clinical Chemistry|March 17, 2007
Detection of vitamin B12 deficiency in older people by measuring vitamin B12 or the active fraction of vitamin B12, holotranscobalaminRobert Clarke, Paul Sherliker, Harold Hin, et al.
The American Journal of Clinical Nutrition|April 7, 2007
Holo-transcobalamin is an indicator of vitamin B-12 absorption in healthy adults with adequate vitamin B-12 statusKristina M von Castel-Roberts, Anne Louise Morkbak, Ebba Nexo, et al.
Age and Ageing|May 20, 2006
Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 studyHarold Hin, Robert Clarke, Paul Sherliker, et al.
Breast Cancer Research and Treatment|April 15, 2008
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrantThomas Frogne, Rikke V Benjaminsen, Katrine Sonne-Hansen, et al.
Pageof 15